Boulding Mark Elliott bought PTCT
June 17, 2026 · Form 4 insider transaction
Boulding Mark Elliott bought 2,012 shares of PTC Therapeutics, Inc. at $46.54 per share, a transaction worth $93.6K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,012
Price
$46.54
Total value
$93.6K
InsiderBoulding Mark Elliott
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 17, 2026
Filing dateJune 22, 2026
Shares owned after107,284
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025.